102 related articles for article (PubMed ID: 20853354)
1. Percutaneous device closure of congenital and iatrogenic ventricular septal defects in adult patients.
Al-Kashkari W; Balan P; Kavinsky CJ; Cao QL; Hijazi ZM
Catheter Cardiovasc Interv; 2011 Feb; 77(2):260-7. PubMed ID: 20853354
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous closure of an iatrogenic ventricular septal defect following mechanical aortic valve replacement using the transseptal technique.
Klein AJ; Garcia JA; Carroll JD
Catheter Cardiovasc Interv; 2007 Dec; 70(7):1018-24. PubMed ID: 17621666
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter closure of a traumatic VSD in an adult requiring an ASD occluder device.
Suh WM; Kern MJ
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1120-5. PubMed ID: 19642200
[TBL] [Abstract][Full Text] [Related]
4. Novel transcatheter closure of an iatrogenic perimembranous ventricular septal defect.
Retzer EM; Dill KE; Shah AP
Catheter Cardiovasc Interv; 2015 Jan; 85(1):161-5. PubMed ID: 25176592
[TBL] [Abstract][Full Text] [Related]
5. Shunt reduction with a fenestrated Amplatzer device.
Kretschmar O; Sglimbea A; Corti R; Knirsch W
Catheter Cardiovasc Interv; 2010 Oct; 76(4):564-71. PubMed ID: 20882662
[TBL] [Abstract][Full Text] [Related]
6. Ventricular septal defect closure in a small children with the Amplatzer Duct Occluder II.
El Tahlawi M; Kammache I; Fraisse A
Catheter Cardiovasc Interv; 2011 Feb; 77(2):268-71. PubMed ID: 21290557
[TBL] [Abstract][Full Text] [Related]
7. Residual VSD closure with an ADO II device in an infant.
Ramakrishnan S; Saxena A; Choudhary SK
Congenit Heart Dis; 2011; 6(1):60-3. PubMed ID: 21269415
[TBL] [Abstract][Full Text] [Related]
8. Interatrial shunt closure devices in patients with nickel allergy.
Reddy BT; Patel JB; Powell DL; Michaels AD
Catheter Cardiovasc Interv; 2009 Oct; 74(4):647-51. PubMed ID: 19777603
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure of perimembranous ventricular septal defect in children: safety and efficiency with symmetric and asymmetric occluders.
Yang R; Sheng Y; Cao K; Kong X; Xu D; Yong Y; Zhou L; Zhang H; Qian L; Sun W; Gu Z
Catheter Cardiovasc Interv; 2011 Jan; 77(1):84-90. PubMed ID: 20928839
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter perimembranous ventricular septal defect closure with atrial septal occluder.
Mahimarangaiah J; Srivastava A; Hemanasetty S
J Invasive Cardiol; 2010 Jul; 22(7):E122-4. PubMed ID: 20603513
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter Closure of Iatrogenic VSDs after Aortic Valve Replacement Surgery: 2 Case Reports and a Literature Review.
Taleyratne JD; Henderson RA
Tex Heart Inst J; 2016 Aug; 43(4):329-33. PubMed ID: 27547145
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter closure of perimembranous VSD: symmetric and asymmetric occluders.
Lucas V
Catheter Cardiovasc Interv; 2011 Jan; 77(1):91. PubMed ID: 21181972
[No Abstract] [Full Text] [Related]
13. Technology Insight: transcatheter closure of ventricular septal defects.
Moodie DS
Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):592-6. PubMed ID: 16258571
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device.
Chessa M; Carminati M; Cao QL; Butera G; Giusti S; Bini RM; Hijazi ZM
J Invasive Cardiol; 2002 Jun; 14(6):322-7. PubMed ID: 12042624
[TBL] [Abstract][Full Text] [Related]
15. Post-traumatic ventricular septal defects--review of the literature and a novel technique for percutaneous closure.
Dehghani P; Ibrahim R; Collins N; Latter D; Cheema AN; Chisholm RJ
J Invasive Cardiol; 2009 Sep; 21(9):483-7. PubMed ID: 19726824
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter membranous ventricular septal defect closure through a mechanical aortic prosthesis using the Amplatzer membranous ventricular septal defect occluder.
Noble S; Ibrahim R
Catheter Cardiovasc Interv; 2009 Feb; 73(2):167-72. PubMed ID: 19085913
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
Carminati M; Butera G; Chessa M; Drago M; Negura D; Piazza L
Am J Cardiol; 2005 Dec; 96(12A):52L-58L. PubMed ID: 16399093
[TBL] [Abstract][Full Text] [Related]
18. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device.
Bass JL; Kalra GS; Arora R; Masura J; Gavora P; Thanopoulos BD; Torres W; Sievert H; Carminati M; Fischer G; Ewert P
Catheter Cardiovasc Interv; 2003 Feb; 58(2):238-45. PubMed ID: 12552550
[TBL] [Abstract][Full Text] [Related]
19. Continued controversy regarding adverse events after Amplatzer septal device closure: mass hysteria or tip of the iceberg?
DiBardino DJ; Mayer JE
J Thorac Cardiovasc Surg; 2011 Jul; 142(1):222-3. PubMed ID: 21683840
[No Abstract] [Full Text] [Related]
20. Transcatheter closure of congenital muscular ventricular septal defect.
Arora R; Trehan V; Thakur AK; Mehta V; Sengupta PP; Nigam M
J Interv Cardiol; 2004 Apr; 17(2):109-15. PubMed ID: 15104774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
